Caption Management, LLC United Therapeutics Corp Call Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $7.76 Million - $10.8 Million	34,000 New	34,000 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $3.08 Million - $3.49 Million	15,000 New	15,000 $3.31 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $8.13 Million - $9.77 Million	40,000 Added 200.0%	60,000 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $3.5 Million - $4.82 Million	20,000 New	20,000 $4.71 Million
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $3.32 Million - $4.28 Million	-20,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$184.32 - $216.08 $3.69 Million - $4.32 Million	20,000 New	20,000 $4.32 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $2.56 Million - $3.18 Million	-15,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $2.31 Million - $2.62 Million	15,000 New	15,000 $2.51 Million
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $1.96 Million - $2.38 Million	-25,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $1.87 Million - $2.15 Million	25,000 New	25,000 $1.99 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.